- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Decadron
Total 588 results
-
BayerCompleted
-
Masonic Cancer Center, University of MinnesotaTerminated
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
Baylor College of MedicineCompletedHodgkin DiseaseUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAmyloidosis | Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Systemic Mastocytosis | Recurrent... and other conditionsUnited States
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
Montefiore Medical CenterCompletedNephrolithiasisUnited States
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Ph-Like Acute Lymphoblastic Leukemia | Refractory Ph-Like Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARAUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Mayo ClinicKnee SocietyCompletedStiffness Following Total Knee ArthroplastyUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterCompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasmacytoma | POEMS SyndromeUnited States
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Plasmacytoma | Plasma Cell LeukemiaUnited States
-
Massachusetts General HospitalSanofi; AmgenActive, not recruiting
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminated
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
pharmaand GmbHTerminated
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Joseph TuscanoTakeda; CelgeneActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Novartis; Lymphoma Research FoundationCompleted
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.TerminatedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
University of ArkansasActive, not recruitingMyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of ArkansasActive, not recruitingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionMultiple MyelomaUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
University of Alabama at BirminghamCompletedPain, Postoperative | Urethral StrictureUnited States
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupTerminated